Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone

NCT00458796 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1500

Enrollment

OTHER

Sponsor class

Stopped Lower than expected recruitment

Conditions

Breast Cancer
Hypercalcemia of Malignancy
Metastatic Cancer
Musculoskeletal Complications
Pain

Interventions

DRUG: zoledronic acid
PROCEDURE: quality-of-life assessment

Sponsor

University of Leeds

Collaborators

[object Object]